Sosina Makonnen Selected Research

Sosina Makonnen Research Topics

14	Neoplasms (Cancer) 10/2022 - 01/2003
2	Ovarian Neoplasms (Ovarian Cancer) 12/2020 - 01/2019
1	Lung Neoplasms (Lung Cancer) 10/2021
1	Cytokine Release Syndrome 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Melanoma (Melanoma, Malignant) 11/2007
1	Hypoxia (Hypoxemia) 11/2007

3	AntibodiesIBA 01/2021 - 01/2018
2	Immunoconjugates (Immunoconjugate)IBA 10/2021 - 01/2017
2	AntigensIBA 01/2021 - 01/2017
2	Bispecific AntibodiesIBA 01/2021 - 01/2019
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	theasinensin AIBA 01/2021
1	Blocking AntibodiesIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	cemiplimabIBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	CA-125 Antigen (CA 125 Antigen)IBA 01/2019
1	Maytansine (Maitansine)IBA 01/2018
1	epidermal growth factor receptor VIIIIBA 01/2018
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2018
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2017
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2017
1	Oxygen (Dioxygen)IBA 01/2008
1	NitroimidazolesIBA 11/2007
1	Sorafenib (BAY 43-9006)FDA Link 11/2006
1	Phosphotransferases (Kinase)IBA 11/2006
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2006
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2005
1	CytokinesIBA 12/2003
1	Interleukin-12 (IL 12)IBA 01/2003
1	Indicators and Reagents (Reagents)IBA 01/2003

6	Therapeutics 10/2021 - 01/2003
2	Immunotherapy 10/2022 - 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 01/2019
1	Radiotherapy 11/2007